These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 923077)
1. Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma. Bannister SJ; Sternson LA; Repta AJ; James GW Clin Chem; 1977 Dec; 23(12):2258-62. PubMed ID: 923077 [TBL] [Abstract][Full Text] [Related]
2. Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II). Bannister SJ; Chang Y; Sternson LA; Repta AJ Clin Chem; 1978 Jun; 24(6):877-80. PubMed ID: 657475 [TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum(II) in plasma ultrafiltrate. Augey V; Cociglio M; Galtier M; Yearoo R; Pinsani V; Bressolle F J Pharm Biomed Anal; 1995 Aug; 13(9):1173-8. PubMed ID: 8573645 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method. Drummer OH; Proudfoot A; Howes L; Louis WJ Clin Chim Acta; 1984 Jan; 136(1):65-74. PubMed ID: 6319051 [TBL] [Abstract][Full Text] [Related]
5. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate. Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560 [TBL] [Abstract][Full Text] [Related]
6. Energy-dispersive X-ray fluorescence determination of platinum in plasma, urine, and cerebrospinal fluid of patients administered cis-dichlorodiammineplatinum(II). Seifert WE; Stewart DJ; Benjamin RS; Caprioli RM Cancer Chemother Pharmacol; 1983; 11(2):120-3. PubMed ID: 6685002 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. Mitsui A; Nohta H; Ohkura Y J Chromatogr; 1985 Nov; 344():61-70. PubMed ID: 3003137 [TBL] [Abstract][Full Text] [Related]
8. Determination of cis-diamminedichloroplatinum(II) in human plasma using ion-pair chromatography with electrochemical detection. Parsons PJ; LeRoy AF J Chromatogr; 1986 Jun; 378(2):395-408. PubMed ID: 3733997 [TBL] [Abstract][Full Text] [Related]
9. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate. Andrews PA; Wung WE; Howell SB Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065 [TBL] [Abstract][Full Text] [Related]
10. Platinum determination in cis-dichlorodiammineplatinum(II)--DNA complexes by differential pulse polarography. Vrána O; Brabec V Anal Biochem; 1984 Oct; 142(1):16-23. PubMed ID: 6542757 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of four platinum cytostatics in rats. Láznícková A; Filipová M; Láznícek M; Drobník J; Svoboda D; Kvĕtina J Neoplasma; 1987; 34(2):173-81. PubMed ID: 3600883 [TBL] [Abstract][Full Text] [Related]
12. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection. Parsons PJ; Morrison PF; LeRoy AF J Chromatogr; 1987 Jan; 385():323-35. PubMed ID: 3558589 [TBL] [Abstract][Full Text] [Related]
13. Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection. de Waal WA; Maessen FJ; Kraak JC J Chromatogr; 1987 Oct; 407():253-72. PubMed ID: 3429508 [TBL] [Abstract][Full Text] [Related]
14. Determination of cisplatin and related platinum complexes in plasma ultrafiltrate and urine by high-performance liquid chromatography with on-line radioactivity detection. Baldew GS; Volkers KJ; De Goeij JJ; Vermeulen NP J Chromatogr; 1989 Jun; 491(1):163-74. PubMed ID: 2793971 [TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072 [TBL] [Abstract][Full Text] [Related]
16. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS. Nguyen TT; Østergaard J; Stürup S; Gammelgaard B Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma. Allain P; Berre S; Mauras Y; Le Bouil A Biol Mass Spectrom; 1992 Mar; 21(3):141-3. PubMed ID: 1576172 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II). Vermorken JB; van der Vijgh WJ; Pinedo HM Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316 [TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of tamoxifen, an anti-neoplastic agent, in plasma. Mendenhall DW; Kobayashi H; Shih FM; Sternson LA; Higuchi T; Fabian C Clin Chem; 1978 Sep; 24(9):1518-24. PubMed ID: 688611 [TBL] [Abstract][Full Text] [Related]
20. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection. Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]